Alzheimer’s Disease Risk Variants Show Association With Cerebrospinal Fluid Amyloid Beta

Neurogenetics - Germany
doi 10.1007/s10048-008-0150-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease

Neuron
Neuroscience
2013English

Genome-Wide Association Studies for Cerebrospinal Fluid Soluble TREM2 in Alzheimer’s Disease

Frontiers in Aging Neuroscience
AgingCognitive Neuroscience
2019English

Longitudinal Assessment of Tau and Amyloid Beta in Cerebrospinal Fluid of Parkinson Disease

Acta Neuropathologica
Forensic MedicineMolecular NeurosciencePathologyNeurologyCellular
2013English

Increased PCSK9 Cerebrospinal Fluid Concentrations in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2016English

Cerebrospinal Fluid Soluble TREM2 in Aging and Alzheimer’s Disease

Alzheimer's Research and Therapy
NeurologyCognitive Neuroscience
2016English

Neuropsychiatric Correlates of Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease

Dementia and Geriatric Cognitive Disorders
PsychiatryGerontologyGeriatricsMental HealthCognitive Neuroscience
2008English

Cerebrospinal Fluid PKR Level Predicts Cognitive Decline in Alzheimer’s Disease

PLoS ONE
Multidisciplinary
2013English

Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer’s Disease

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2019English

Proteomics-Derived Cerebrospinal Fluid Markers of Autopsy-Confirmed Alzheimer’s Disease

Biomarkers
MutagenesisClinical BiochemistryBiochemistryHealthMedicineToxicology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy